EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Serum Interleukin-19 level in Women with Polyendocrine Metabolic Ovarian Syndrome

Tharwa H. Al-Tai, Jalal A. Al-Saedi, Hayfaa S. AL-Hadithi, Tariq G. Nadeem

Journal of the Faculty of Medicine Baghdad · 01.07.2026 · 68 (2) · 145-151

DOI: 10.32007/jfacmedbaghdad3321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Faculty of Medicine Baghdad, online erschienen am 01.07.2026. Verfasst von Tharwa H. Al-Tai und 3 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polyendocrine Metabolic Ovarian Syndrome (PMOS) typically affects women aged 15 to 50. According to recent studies, immune cells and hormonal imbalances have a role in the pathogenesis of PMOS. The causes and effects of chronic inflammation, particularly in women with PMOS, have been the focus of research.

Objectives

To better understand the immunological profile of PMOS patients through investigating the role of IL-19 blood levels as a biomarker or inflammatory mediator and examining its possible involvement in the pathophysiology of the syndrome. Cases and Methods: This is a case-control study conducted between December 2024 and March 2025. Sixty women with PMOS were diagnosed at Kamal Al-Samarrai Specialized Hospital in Baghdad, Iraq. 30 healthy women attending private laboratories were used as a control group, matched for age (18-36) to the cases. The blood samples were centrifuged and allowed to clot at room temperature. The serum was then obtained using the enzyme-linked immunosorbent test (ELISA) for use in the human IL-19 detection method.

Results

The mean age was 26.0±4.90 years for the patients and 25.3±4.45 years for the controls. The mean Body Mass Index (BMI) of the control group was 21.9±2.01 kg/m² compared to 28.9±3.62 kg/m² for the patients in PMOS women; the mean serum IL-19 was 113.2±61.56 pg/ml, significantly higher than that of the control group (6.2±4.28 pg/ml).

Conclusion

The inflammatory environment of PMOS seems to be significantly influenced by interleukin-19. The higher blood IL-19 levels in the PMOS cases suggest that it may have a role in the pathophysiology of the syndrome, potentially connected to follicular dysfunction and insulin resistance. IL-19 may be a potential biomarker for tracking the persistent low-grade inflammation linked to PMOS, providing fresh perspectives on tailored diagnostic and treatment approaches.

Zitieren

APA

Al-Tai, T. H., Al-Saedi, J. A., AL-Hadithi, H. S., & Nadeem, T. G. (2026). Evaluation of Serum Interleukin-19 level in Women with Polyendocrine Metabolic Ovarian Syndrome. Journal of the Faculty of Medicine Baghdad, 68(2), 145-151. https://doi.org/10.32007/jfacmedbaghdad3321

Vancouver

Al-Tai TH, Al-Saedi JA, AL-Hadithi HS, Nadeem TG. Evaluation of Serum Interleukin-19 level in Women with Polyendocrine Metabolic Ovarian Syndrome. Journal of the Faculty of Medicine Baghdad. 2026;68(2):145-151. doi:10.32007/jfacmedbaghdad3321

BibTeX
@article{AlTai2026,
  author = {Al-Tai, Tharwa H. and Al-Saedi, Jalal A. and AL-Hadithi, Hayfaa S. and Nadeem, Tariq G.},
  title = {Evaluation of Serum Interleukin-19 level in Women with Polyendocrine Metabolic Ovarian Syndrome},
  journal = {Journal of the Faculty of Medicine Baghdad},
  year = {2026},
  volume = {68},
  number = {2},
  pages = {145--151},
  doi = {10.32007/jfacmedbaghdad3321}
}
Kostenlos starten →